[HTML][HTML] Pharmacokinetics, pharmacodynamics, and dosing considerations of novel β-lactams and β-lactam/β-lactamase inhibitors in critically ill adult patients: focus …

D Bakdach, R Elajez, AR Bakdach, A Awaisu… - Journal of Clinical …, 2022 - mdpi.com
Objective: Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary
given the increased prevalence of multidrug-resistant infections in intensive care units …

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on …

D Bakdach, R Elajez, A Bakdach, A Awaisu… - Journal of Clinical …, 2022 - europepmc.org
Objective: Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary
given the increased prevalence of multidrug-resistant infections in intensive care units …

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on …

D Bakdach, R Elajez, AR Bakdach, A Awaisu… - 2022 - qspace.qu.edu.qa
Objective: Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary
given the increased prevalence of multidrug-resistant infections in intensive care units …

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on …

D Bakdach, R Elajez, AR Bakdach… - Journal of Clinical …, 2022 - search.proquest.com
Objective: Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary
given the increased prevalence of multidrug-resistant infections in intensive care units …

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on …

D Bakdach, R Elajez, AR Bakdach… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary
given the increased prevalence of multidrug-resistant infections in intensive care units …

[HTML][HTML] Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients …

D Bakdach, R Elajez, AR Bakdach… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Objective: Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary
given the increased prevalence of multidrug-resistant infections in intensive care units …

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on …

D Bakdach, R Elajez, AR Bakdach… - Journal of Clinical …, 2022 - search.ebscohost.com
Objective: Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary
given the increased prevalence of multidrug-resistant infections in intensive care units …

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on …

D Bakdach, R Elajez, AR Bakdach… - Journal of Clinical …, 2022 - europepmc.org
Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary given the
increased prevalence of multidrug-resistant infections in intensive care units coupled with …